Michael King

WORK HISTORY

EDUCATION

SKILLS

ABOUT MICHAEL KING

CORE EXPERTISE: • Drug development from Ph 0 to Ph 4, in neuropsychiatry, pain/analgesics, neurological disorders, sleep disorders, diabetes, obesity, and NASH, immune/inflammatory disorders, rare blood disorder, cancer.• Multi-functional clinical and operational compound team leader (from Phase 1 to Phase 4).• Development of clinical development plans.• Develop and implement global compound clinical strategy.• Develop and implement global risk management plans.• Development of study/program budgets and timelines.• Clinical development of small molecules, proteins and mAb.• Managing clinical development across alliances (collaborating companies).• Preparation of regulatory documents (IND, NDA, CTA, MAA, CTN).• Operational strategy and execution of decentralized clinical trials.• Integration of remote clinical components, telemedicine and connected medical devices into clinical trials.• Clinical Digital Innovation.• Pediatric drug development (diabetes, pain, sleep disorder).• Design and development of biomarker/proof of concept clinical trials.• Clinical pharmacogenomic and biomarker global operations.• Clinical translational medicine (diabetes, immune disorders, pain, psychological and neurological disorders, oncology, sleep disorders).• Clinical and operational leadership/managerial.• Research expertise in pain, diabetes, epilepsy, Alzheimer’s disease, multiple sclerosis, anxiety and depression.• Experience with both foreign and domestic pharmaceutical firms with respect to the potential licensing of novel metabolic, CNS and analgesic agents.• Publication and presentation of scientific results.